The practice of substituting a cheaper, generic, medication for a brand-name medication. This can be mandated by the state to occur at the point of sale or can occur at consumer request. NMHA is not opposed to the use of generic medication, as this is a reasonable mechanism that can be used to cut costs to the pharmacy budget when appropriate for specific individuals. However, clinicians and consumers must be aware when such policies are in place. The key factor is the ability for clinicians and consumers to choose the best option for all available types of medication therapies.
the switching of a branded drug for a generic version of the same compound, usually by a health plan or pharmacy benefits manager, as part of drug utilization review. Generic substitution is based on the belief that branded and generic versions of the same compound are exactly the same drug - even though they are often made in different ways, often using different sources of ingredients. If a generic is available, many health plans will not pay for the branded version, no matter how strongly the doctor or patient feels about sticking to the brand. A common example of generic substitution is the switching of a branded drug like Zovirax to the generic Acyclovir.
dispensing of a generic drug in place of a brand name drug. Generic drugs must contain the same active ingredients as the brand name drugs.